Menu Menu

LCTX    Lineage Cell Therapeutics Inc    876343    
Income Statement
Revenue 3,779,000
Net Income -3,034,000
Profit Margin -80.29%

Balance Sheet
Current Assets 34,401,000
Assets 96,594,000
Current Liabilities 13,864,000
Liabilities 31,800,000
Equity 64,794,000
Shares Out 188,837,000

Cash Flow Statement
Operating Cash Flow -16,746,000
Investing Cash Flow -4,943,000

Market Analysis
Market Cap 174,293,939
Price 0.59
BVPS 0.34
PB 1.69
EPS -0.13
PS 11.53
FCF -21,689,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
3/07 0.26
Apr May Jun
5/09 -0.04
Jul Aug Sep
8/08 -0.03
Oct Nov Dec
11/07

Find a discrepancy? The most accurate way to find company fundamental data is to view LCTX documents filed with the SEC.


LCTX Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: